title: The MS-5 murine stromal cell line and hematopoietic growth factors synergize to support the megakaryocytic differentiation of embryonic stem cells.
abstract: Murine embryonic stem (ES) cells are able to differentiate into erythroid, mast, and granulomonocytic cells by using appropriate culture conditions. Because we were interested in the regulation of tissue-specific expression of the platelet glycoprotein IIb gene, we studied the culture conditions, aiming at the reproducible production of myeloid cells that included megakaryocytes (MKs) from ES cells. We showed that even a complex cocktail of HGFs (stem cell factor, interleukin 3, IL6, IL11, granulocyte colony-stimulating factor, and erythropoietin) is unable to induce significant myeloid differentiation in day 12 embryoid bodies. Cocultures of MS-5 stromal cells with ES cells were slightly more productive than HGFs. A strong synergistic effect was observed on the growth of myeloid colonies and MKs when we used a combination of MS-5 cells plus the HGF cocktail. Conditioned medium from MS-5 cells also synergized with the HGF cocktail to produce a substantial number of mixed colonies containing MKs. The addition of fibroblast growth factor-2 (FGF-2) to the HGF cocktail plus MS-5 nearly doubled the number of myeloid progenitors, including those with MKs. Thrombopoietin (TPO) alone or in any combination with MS-5 or HGFs, did not increase the number of MK-containing colonies. However, when TPO was added to the HGF cocktail + FGF-2 + MS-5, the number of MKs in liquid cultures and mixed colonies increased, and many exhibited a "hairy" appearance resembling pseudopodial proplatelet formation. Having defined the culture conditions of ES cells that allow the production of all the myeloid lineages including MKs, we conclude that the hematopoietic differentiation model of ES cells is especially useful for studying the regulation of expression of any gene important in early hematopoiesis.
authors.affiliation: CEA, Laboratoire d'Hématologie, INSERM U217, Grenoble, France.
authors.forename: R
authors.initials: R
authors.lastname: Berthier
authors.forename: M H
authors.initials: MH
authors.lastname: Prandini
authors.forename: A
authors.initials: A
authors.lastname: Schweitzer
authors.forename: D
authors.initials: D
authors.lastname: Thevenon
authors.forename: H
authors.initials: H
authors.lastname: Martin-Sisteron
authors.forename: G
authors.initials: G
authors.lastname: Uzan
mesh_terms: D000818:Animals; D001755:Blastocyst / Q000166:cytology*; D001854:Bone Marrow Cells; D002454:Cell Differentiation; D002460:Cell Line; D002478:Cells, Cultured; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D015870:Gene Expression; D006410:Hematopoiesis; D016298:Hematopoietic Cell Growth Factors / Q000494:pharmacology*; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D008533:Megakaryocytes / Q000166:cytology*; D051379:Mice; D012333:RNA, Messenger / Q000235:genetics; D013234:Stem Cells / Q000166:cytology*; D013926:Thrombopoietin / Q000494:pharmacology
chemical_list: D016298:Hematopoietic Cell Growth Factors; D012333:RNA, Messenger; D016222:Fibroblast Growth Factor 2; D013926:Thrombopoietin